Experts hail highly successful trial of Lilly's cholesterol-busting drug lepodisiran
Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...
Asianet Newsable on MSN50m
Novo Nordisk’s Controlling Shareholder Novo Holdings Reports Record Total Income, Investment Returns In 2024: Retail Stays Bullish
Novo Holdings, the controlling shareholder of drug maker Novo Nordisk, said on Wednesday that its total income and investment return in 2024 nearly doubled to DKK 60 billion ($8.69 billion), hitting a ...